These alterations contribute directly to the development of hyperglycemia, followed by pancreatic β-cells increasing insulin secretion impaired insulin signaling in skeletal muscle, which results in chronic hyperinsulinemia, culminating in the development of type 2 DM [44]. The gene discussed is INS; the disease is hyperinsulinism.